IRIS
Grandi, Guido
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.949
AS - Asia 2.733
EU - Europa 1.574
SA - Sud America 684
Continente sconosciuto - Info sul continente non disponibili 291
AF - Africa 67
OC - Oceania 11
Totale 12.309
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.848
SG - Singapore 964
VN - Vietnam 691
CN - Cina 571
BR - Brasile 544
IT - Italia 321
RU - Federazione Russa 287
SE - Svezia 164
FI - Finlandia 159
GB - Regno Unito 122
FR - Francia 108
LV - Lettonia 91
DE - Germania 90
HK - Hong Kong 88
KR - Corea 74
TR - Turchia 62
BG - Bulgaria 60
ID - Indonesia 60
IN - India 56
AR - Argentina 55
BD - Bangladesh 52
CA - Canada 44
MX - Messico 32
EC - Ecuador 30
UA - Ucraina 29
IQ - Iraq 24
ZA - Sudafrica 24
NL - Olanda 23
PL - Polonia 22
CO - Colombia 20
ES - Italia 19
AT - Austria 18
CL - Cile 13
JP - Giappone 12
AU - Australia 10
CZ - Repubblica Ceca 10
PK - Pakistan 10
DZ - Algeria 8
MA - Marocco 8
SK - Slovacchia (Repubblica Slovacca) 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
PE - Perù 7
TH - Thailandia 7
UZ - Uzbekistan 7
VE - Venezuela 7
BE - Belgio 6
PH - Filippine 6
PY - Paraguay 6
EG - Egitto 5
IE - Irlanda 5
KE - Kenya 5
KZ - Kazakistan 5
PT - Portogallo 5
RO - Romania 5
HN - Honduras 4
IL - Israele 4
JO - Giordania 4
LT - Lituania 4
SA - Arabia Saudita 4
TW - Taiwan 4
AM - Armenia 3
ET - Etiopia 3
JM - Giamaica 3
NP - Nepal 3
PR - Porto Rico 3
BB - Barbados 2
BW - Botswana 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GR - Grecia 2
GT - Guatemala 2
IR - Iran 2
KG - Kirghizistan 2
LB - Libano 2
NI - Nicaragua 2
PA - Panama 2
RS - Serbia 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
HR - Croazia 1
KH - Cambogia 1
LK - Sri Lanka 1
MD - Moldavia 1
MQ - Martinica 1
MU - Mauritius 1
NO - Norvegia 1
Totale 12.014
Salva come PNG Salva come JPEG
Città #
Fairfield 852
Ashburn 626
Singapore 596
Chandler 494
Woodbridge 390
Seattle 374
Houston 322
Wilmington 315
Cambridge 309
San Jose 245
Columbus 225
Santa Clara 220
Ho Chi Minh City 190
Dallas 181
Ann Arbor 178
Princeton 164
Jacksonville 152
Beijing 151
San Mateo 151
Council Bluffs 147
Hanoi 133
Moscow 125
Riga 91
Dong Ket 90
The Dalles 90
Helsinki 85
Hong Kong 84
Lauterbourg 80
Los Angeles 73
Seoul 73
Hangzhou 69
New York 66
Sofia 57
Phoenix 56
Trento 56
San Diego 55
Dearborn 53
Izmir 51
São Paulo 45
Da Nang 40
Jakarta 39
San Paolo di Civitate 33
Chicago 32
Buffalo 30
Orem 30
London 25
Como 24
Haiphong 24
Munich 24
Boardman 21
Rio de Janeiro 20
Rome 18
Warsaw 18
Chennai 16
Norwalk 16
Altamura 15
Johannesburg 15
Guangzhou 14
Hefei 14
Atlanta 13
Biên Hòa 13
Montreal 13
Brooklyn 12
Hải Dương 12
Milan 12
Nuremberg 12
Thái Bình 11
Toronto 11
Baghdad 10
Can Tho 10
Des Moines 10
Quito 10
Redondo Beach 10
Salt Lake City 10
Tokyo 10
Brasília 9
Frankfurt am Main 9
Nanjing 9
Ninh Bình 9
Shanghai 9
Stockholm 9
Belo Horizonte 8
Boston 8
Bratislava 8
Brno 8
Bắc Ninh 8
Fortaleza 8
Fremont 8
Manchester 8
Mexico City 8
Naples 8
Schio 8
Tavagnacco 8
Turku 8
Amsterdam 7
Campinas 7
Denver 7
Düsseldorf 7
Guarulhos 7
Medellín 7
Totale 8.561
Salva come PNG Salva come JPEG
Nome #
Prochymosin expression in Bacillus subtilis 254
Structure of the type IX Group B Streptococcus capsular polysaccharide and its evolutionary relationship with types V and VII 239
Protectome analysis: A new selective bioinformatics tool for bacterial vaccine candidate discovery 239
Some Gram-negative lipoproteins keep their surface topology when transplanted from one species to another and deliver foreign polypeptides to the bacterial surface 234
Vaccination with a FAT1-derived B cell epitope combined with tumor-specific B and T cell epitopes elicits additive protection in cancer mouse models 234
Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus 220
Auto-assembling detoxified staphylococcus aureus alpha-hemolysin mimicking the wild-type cytolytic toxin 220
Analysis of two-component systems in group B streptococcus shows that RgfAC and the novel FspSR modulate virulence and bacterial fitness 201
One dose of staphylococcus aureus 4C-staph vaccine formulated with a novel TLR7-dependent adjuvant rapidly protects mice through antibodies, effector CD4+ T Cells, and IL-17A 199
Synergistic protective activity of tumor-specific epitopes engineered in bacterial outer membrane vesicles 199
The human pathogen Streptococcus pyogenes releases lipoproteins as lipoprotein-rich membrane vesicles 198
Streptococcus agalactiae capsule polymer length and attachment is determined by the proteins CpsABCD 197
Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for Staphylococcus aureus vaccine 197
Whole-genome epidemiology, characterisation, and phylogenetic reconstruction of Staphylococcus aureus strains in a paediatric hospital 189
CD81 extracellular domain 3D structure: Insight into the tetraspanin superfamily structural motifs 186
Vaccinology: The art of putting together the right ingredients 183
Protective effect of Group B Streptococcus type-III polysaccharide conjugates against maternal colonization, ascending infection and neonatal transmission in rodent models 181
Negatively charged AuNP modified with monoclonal antibody against novel tumor antigen FAT1 for tumor targeting 181
Large scale validation of an efficient CRISPR/Cas-based multi gene editing protocol in Escherichia coli 181
Understanding the Molecular Determinants Driving the Immunological Specificity of the Protective Pilus 2a Backbone Protein of Group B Streptococcus 174
Angiopoietin-like 7, a novel pro-angiogenetic factor over-expressed in cancer 173
Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow 170
Proteome-minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform 166
Genomic analysis reveals the molecular basis for capsule loss in the group B Streptococcus population 165
Targeted amino acid substitutions impair streptolysin O toxicity and group a Streptococcus virulence 163
New insights into the role of the glutamic acid of the E-box motif in group B Streptococcus pilus 2a assembly. 162
A structure-based approach to rationally design a chimeric protein for an effective vaccine against Group B Streptococcus infections. 160
FAT1: A potential target for monoclonal antibody therapy in colon cancer 158
Approach to discover T and B cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines. 153
Structural Basis for Group B Streptococcus Pilus 1 Sortases C Regulation and Specificity 152
Structural vaccinology starts to deliver 150
Cloning and nucleotide sequence of the isoamylase gene from a strain of Pseudomonas sp 146
Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro 145
ERMP1, a novel potential oncogene involved in UPR and oxidative stress defense, is highly expressed in human cancer 143
Multiple Stepwise Gene Knockout Using CRISPR/Cas9 in Escherichia coli 143
A rapid and versatile site-directed method of mutagenesis for double-stranded plasmid DNA 142
MF59- and Al(OH)3-adjuvanted Staphylococcus aureus (4C-Staph) vaccines induce sustained protective humoral and cellular immune responses, with a critical role for effector CD4 T cells at low antibody titers 142
The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera 141
Sequence and analysis of the genetic locus responsible for surfactin synthesis in Bacillus subtilis 140
Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changes 139
SpyAD, a moonlighting protein of group A Streptococcus contributing to bacterial division and host cell adhesion 136
Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings 136
Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials. 136
Antibacterial vaccine design using genomics and proteomics 135
Engineering outer membrane vesicles 134
Antibody-mediated immunity induced by engineered Escherichia coli Outer Membrane Vesicles (OMVs) carrying heterologous antigens in their lumen 132
Rational antibacterial vaccine design through genomic technologies 131
A novel polyclonal antibody library for expression profiling of poorly characterized, membrane and secreted human proteins. 130
Commensal Bifidobacterium Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines 128
Structure and protective efficacy of the Staphylococcus aureus autocleaving protease EpiP 127
Three-dimensional human skin models to understand Staphylococcus aureus skin colonization and infection 127
Outer membrane vesicles from the gut microbiome contribute to tumor immunity by eliciting cross-reactive T cells 123
Crystal structures of the components of the Staphylococcus aureus leukotoxin ED 121
Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant women. 120
Four-component Staphylococcus aureus vaccine 4C-staph enhances fcγ receptor expression in neutrophils and monocytes and mitigates S. aureus infection in neutropenic mice 117
The impact of genomics in vaccine discovery: achievements and lessons 117
Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 114
Sortase A substrate specificity in GBS pilus 2a cell wall anchoring. 114
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine 110
Streptococcus pyogenes SpyCEP influences host-pathogen interactions during infection in a murine air pouch model 110
Staphylococcus aureus FhuD2 is involved in the early phase of staphylococcal dissemination and generates protective immunity in mice. 109
Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen. 105
Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles 103
A Bacillus subtilis large ORF coding for a polypeptide highly similar to polyketide synthases. 102
Cumulative stabilizing effects of hydrophobic interactions on the surface of the neutral protease from Bacillus subtilis 97
Structural vaccinology starts to deliver 97
Multi High-Throughput Approach for Highly Selective Identification of Vaccine Candidates: the Group A Streptococcus Case. 97
Immobilized metal-ion affinity chromatography of human growth hormone 96
Gene expression profile in Neisseria meningitidis and Neisseria lactamica upon host-cell contact: from basic research to vaccine development 95
Recombinant and truncated tetanus neurotoxin light chain: Cloning, expression, purification, and proteolytic activity 95
Identification of vaccine candidates against serogroup B meningococcus genome sequencing. 93
Structure and protective efficacy of the Staphylococcus aureus autocleaving protease EpiP 92
The complete genome sequence of the gram-positive bacterium Bacillus subtilis 91
TCTN2: A novel tumor marker with oncogenic properties 90
Structural and functional characterization of the Staphylococcus aureus virulence factor and vaccine candidate FhuD2 89
Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells 87
Surface Interactome in Streptococcus pyogenes. 85
Phagocyte subsets and lymphocyte clonal deletion behind ineffective immune response to Staphylococcus aureus 85
R-factor mediated suppression of the galacto-sensitive phenotype of E.coli K12 galE mutants. 83
Mining the bacterial unknown proteome: Identification and characterization of a novel family of highly conserved protective antigens in Staphylococcus aureus 80
tructure analysis and site-directed mutagenesis of defined key residues and motives for pilus-related sortase C1 in group B Streptococcus. 79
Characterization of the locus encoding the [Ni-Fe] sulfhydrogenase from the archaeon Pyrococcus furiosus: evidence for a relationship to bacterial sulfite reductases. 77
Model building of a thermolysin-like protease by mutagenesis. 76
Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitis 75
Structure, dynamics and immunogenicity of a catalytically inactive CXC chemokine-degrading protease SpyCEP from Streptococcus pyogenes 72
Purification of recombinant human growth hormone by isoelectric focusing in a multicompartment electrolyzer with Immobiline membranes. 70
Identification of novel iron-activated and -repressed fur-dependent genes by transcriptome analysis of Neisseria meningitidis group B 67
Meta-analysis of immune-related adverse events in phase 3 clinical trials assessing immune checkpoint inhibitors for lung cancer 67
Efficient conversion of 5-substituted hydantoins to D-amino acids using recombinant E. coli strains 62
Grafting of a calcium binding loop of thermolysin to B. subtilis neutral protease. 54
Rheumatic immune-and nonimmune-related adverse events in phase 3 clinical trials assessing PD-(L)1 checkpoint inhibitors for lung cancer: A systematic review and meta-analysis 53
Investigation on antigen-specific T-cell responses induced by outer membrane vesicles from Escherichia coli Δ60 strain 29
Totale 12.309
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.602
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022875 0 0 18 99 28 42 34 219 59 96 118 162
2022/20231.018 150 154 23 134 89 156 10 80 108 8 57 49
2023/2024339 24 34 21 16 30 46 46 14 4 16 33 55
2024/20251.699 10 6 74 408 60 246 30 90 173 298 105 199
2025/20264.051 246 126 563 965 287 245 683 103 342 275 131 85
2026/2027372 91 204 77 0 0 0 0 0 0 0 0 0
Totale 12.309